Market Overview:
The global carbetocin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of post-partum hemorrhage, rising demand for oxytocics and uterotonics, and growing focus on novel drug delivery technologies. Based on type, the global carbetocin market can be segmented into tablets and injections. The injection segment is expected to account for a larger share of the market than the tablet segment during the forecast period. This can be attributed to factors such as ease of use and faster action time offered by injections as compared to tablets. Based on application, the global carbetocin market can be divided into oxytocic drugs, antihemorrhagic drugs, and uterotonic drugs.
 Industry Outlook.svg)
Product Definition:
A synthetic oxytocic agent used to stimulate uterine contractions and to control postpartum hemorrhage. It is also effective in the prevention of uterine atony and consequent hemorrhage during cesarean section.
Carbetocin Tablets:
Carbetocin is a type of medication that belongs to the family of drugs known as analgesic/antipyretic drugs. It works by decreasing fever and relieving pain. This drug has found its application in cancer treatment, mainly for bone metastasis and also finds its utility in labor pain management.
Carbetocin Injection:
Carbetocin is a carboxylate antibiotic that belongs to the class of drugs known as quinolones. It works by killing the bacteria susceptible to attack. Carbetocin injection is used in veterinary medicine for treating bacterial infections in animals, mainly dogs and cats. The drug has also been approved for use in humans but it can only be administered by doctors after proper training on its safe usage and handling precautions under medical supervision.
Application Insights:
The oxytocic segment dominated the global market in 2017. Oxytocic drugs are used to stimulate contractions during laborious childbirths. The drug is a prostaglandin which causes smooth muscle contraction, thus making uterus contracts and bear down easier. It has been found to be effective than other prostaglandins for inducing labour as it causes less blood vessel dilation and reduces uterine activity.
Carbetocin was approved by the U.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. Increasing incidence of various forms of cancer, growing geriatric population, and rising awareness about early diagnosis are some factors responsible for this growth. Moreover, presence of key manufacturers such as Pfizer Inc.; Ortho-McNeil Pharmaceutical; and Merck & Co., Inc.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast years owing to increasing healthcare expenditure by governments along with rising prevalence of chronic diseases such as diabetes and hypertension that result in an increased risk for cardiovascular disorders among others.
Growth Factors:
- Increasing awareness about the benefits of Carbetocin(Duratocin) in preventing post-partum hemorrhage and its potential to save lives.
- Rising number of pregnant women across the globe, which is expected to drive demand for Carbetocin(Duratocin).
- Launch of new products by key players that are expected to offer better efficacy and safety profile than existing products.
- Growing preference for self-administration over conventional intravenous administration of Carbetocin(Duratocin).
Scope Of The Report
Report Attributes
Report Details
Report Title
Carbetocin(Duratocin) Market Research Report
By Type
Carbetocin Tablets, Carbetocin Injection
By Application
Oxytocic, Antihemorrhagic, Uterotonic
By Companies
Beacon Pharmaceuticals Limited, Ferring Inc., Polypeptide Laboraries France, Chemos GmbH & Co. KG, Hangzhou Dayangchem Co. Ltd., Acinopeptide Co., Ltd., Bachem AG, Clearsynth Canada INC., Leap Labchem Co., Ltd, Chemieliva Pharmaceutical Co., Ltd., Beacon Pharmaceuticals Limited, BOC Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Carbetocin(Duratocin) Market Report Segments:
The global Carbetocin(Duratocin) market is segmented on the basis of:
Types
Carbetocin Tablets, Carbetocin Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oxytocic, Antihemorrhagic, Uterotonic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beacon Pharmaceuticals Limited
- Ferring Inc.
- Polypeptide Laboraries France
- Chemos GmbH & Co. KG
- Hangzhou Dayangchem Co. Ltd.
- Acinopeptide Co., Ltd.
- Bachem AG
- Clearsynth Canada INC.
- Leap Labchem Co., Ltd
- Chemieliva Pharmaceutical Co., Ltd.
- Beacon Pharmaceuticals Limited
- BOC Sciences
 Market Overview.svg)
Highlights of The Carbetocin(Duratocin) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Carbetocin Tablets
- Carbetocin Injection
- By Application:
- Oxytocic
- Antihemorrhagic
- Uterotonic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Carbetocin(Duratocin) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Carbetocin is a medication used to treat pain. It is a type of opioid drug.
Some of the key players operating in the carbetocin(duratocin) market are Beacon Pharmaceuticals Limited, Ferring Inc., Polypeptide Laboraries France, Chemos GmbH & Co. KG, Hangzhou Dayangchem Co. Ltd., Acinopeptide Co., Ltd., Bachem AG, Clearsynth Canada INC., Leap Labchem Co., Ltd, Chemieliva Pharmaceutical Co., Ltd., Beacon Pharmaceuticals Limited, BOC Sciences.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Carbetocin(Duratocin) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Carbetocin(Duratocin) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Carbetocin(Duratocin) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Carbetocin(Duratocin) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Carbetocin(Duratocin) Market Size & Forecast, 2018-2028
4.5.1 Carbetocin(Duratocin) Market Size and Y-o-Y Growth
4.5.2 Carbetocin(Duratocin) Market Absolute $ Opportunity
Chapter 5 Global Carbetocin(Duratocin) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Carbetocin(Duratocin) Market Size Forecast by Type
5.2.1 Carbetocin Tablets
5.2.2 Carbetocin Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Carbetocin(Duratocin) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Carbetocin(Duratocin) Market Size Forecast by Applications
6.2.1 Oxytocic
6.2.2 Antihemorrhagic
6.2.3 Uterotonic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Carbetocin(Duratocin) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Carbetocin(Duratocin) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Carbetocin(Duratocin) Analysis and Forecast
9.1 Introduction
9.2 North America Carbetocin(Duratocin) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Carbetocin(Duratocin) Market Size Forecast by Type
9.6.1 Carbetocin Tablets
9.6.2 Carbetocin Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Carbetocin(Duratocin) Market Size Forecast by Applications
9.10.1 Oxytocic
9.10.2 Antihemorrhagic
9.10.3 Uterotonic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Carbetocin(Duratocin) Analysis and Forecast
10.1 Introduction
10.2 Europe Carbetocin(Duratocin) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Carbetocin(Duratocin) Market Size Forecast by Type
10.6.1 Carbetocin Tablets
10.6.2 Carbetocin Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Carbetocin(Duratocin) Market Size Forecast by Applications
10.10.1 Oxytocic
10.10.2 Antihemorrhagic
10.10.3 Uterotonic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Carbetocin(Duratocin) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Carbetocin(Duratocin) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Carbetocin(Duratocin) Market Size Forecast by Type
11.6.1 Carbetocin Tablets
11.6.2 Carbetocin Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Carbetocin(Duratocin) Market Size Forecast by Applications
11.10.1 Oxytocic
11.10.2 Antihemorrhagic
11.10.3 Uterotonic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Carbetocin(Duratocin) Analysis and Forecast
12.1 Introduction
12.2 Latin America Carbetocin(Duratocin) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Carbetocin(Duratocin) Market Size Forecast by Type
12.6.1 Carbetocin Tablets
12.6.2 Carbetocin Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Carbetocin(Duratocin) Market Size Forecast by Applications
12.10.1 Oxytocic
12.10.2 Antihemorrhagic
12.10.3 Uterotonic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Carbetocin(Duratocin) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Carbetocin(Duratocin) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Carbetocin(Duratocin) Market Size Forecast by Type
13.6.1 Carbetocin Tablets
13.6.2 Carbetocin Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Carbetocin(Duratocin) Market Size Forecast by Applications
13.10.1 Oxytocic
13.10.2 Antihemorrhagic
13.10.3 Uterotonic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Carbetocin(Duratocin) Market: Competitive Dashboard
14.2 Global Carbetocin(Duratocin) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Beacon Pharmaceuticals Limited
14.3.2 Ferring Inc.
14.3.3 Polypeptide Laboraries France
14.3.4 Chemos GmbH & Co. KG
14.3.5 Hangzhou Dayangchem Co. Ltd.
14.3.6 Acinopeptide Co., Ltd.
14.3.7 Bachem AG
14.3.8 Clearsynth Canada INC.
14.3.9 Leap Labchem Co., Ltd
14.3.10 Chemieliva Pharmaceutical Co., Ltd.
14.3.11 Beacon Pharmaceuticals Limited
14.3.12 BOC Sciences
